BioHistory Moment: FDA requested help in removing a hazardous product, "X-33 Water Repellent," from the market
On August 30, 1964, the FDA asked state and local health and safety officials for help in removing "X-33 Water Repellent"
from the market. The extremely flammable product had caused three deaths and more than 30 injuries through flash explosions,
in many cases while it was being used in home basements to waterproof masonry.
Federal oversight of consumer products such as X-33 and many other items used in the home was transferred to the newly
created Consumer Product Safety Commission in 1973. One class of consumer products still regulated by the FDA is
radiation-emitting products.
 More...
Learn about Seattle's PNDRI Life Sciences Incubator Building
A contemporary-designed building provided with modern research systems. Four floors are specifically laboratory space, one floor is a
fully equipped vivarium and one floor is clinical space and management offices.
Learn about biotechnology, medical device and pharmaceutical facilities available for sale,
lease or sublease in Alaska, regionally or nationwide.
More...
(Advertising)
|
|
|
Industry News...
Free News Release Posting & Archiving Service
- European Commission issues positive decision for approval of Seroquel XR AstraZeneca announced the European Commission issued a positive decision for the approval of once-daily SEROQUEL XR Extended Release Tablets as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder who had sub-optimal response to antidepressant monotherapy.
AstraZeneca September 02, 2010
- New England Journal of Medicine reports Xpert MTB/RIF a faster Tuberculosis test New England Journal of Medicine reports Xpert MTB/RIF a faster, more Cepheid announced that its Xpert(R) MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance."
Cepheid September 02, 2010
- Oncolytics Biotech® announces randomized phase II ovarian cancer study Oncolytics Biotech announced that the Gynecologic Oncology Group (GOG) intends to conduct a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN® in patients with persistent or recurrent, ovarian, fallopian tube or primary peritoneal cancer (GOG186H).
Oncolytics Biotech® Inc. September 02, 2010
- Cardiome achieves $30 million milestone with Merck Cardiome Pharma announced that it has earned a US$30 million milestone payment from its collaboration with Merck, through an affiliate. The milestone was triggered by the recently announced marketing approval for BRINAVESSTM (vernakalant (iv)) in the European Union, Iceland and Norway.
Cardiome Pharma Corp. September 02, 2010
- Seattle Genetics achieves milestone under antibody-drug conjugate collaboration Seattle Genetics announced a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, an affiliate of Astellas Pharma. The milestone was triggered by Agensys' initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics' technology.
Seattle Genetics, Inc. September 02, 2010
More... | Submit News Release | Advertising...
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
Surplus Equipent & Supplies for Sale!
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Alaska's BioHistory
Why is there a life science industry in Alaska? Is the industry
growing? What do other states have?
Through Alaska BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industry in Alaska.
More...
BioEvolution Posters
More...
August: National Immunization Awareness Month
The goal of National Immunization Awareness Month (NIAM) is to increase awareness about immunizations across the life
span, from infants to the elderly.
Immunization is one of the most significant public health achievements of the 20th century. Vaccines have
eradicated smallpox, eliminated wild poliovirus in the U.S. and significantly reduced the number of cases of measles,
diphtheria, rubella, pertussis and other diseases. But despite these efforts, people in the U.S. still die from these
and other vaccine-preventable diseases.
More...
BioFact
(1983) - EPA Administrator Anne Burford is forced to resign.
It's a Small World
|
| |
Smallpox Viruses
| |
Science Quote
"There are sadistic scientists who hurry to hunt down errors instead of establishing the truth."
| - |
Marie Curie, French chemist and physicist
|
|
(1867-1934)
|
|
